Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015-2020.

ABSTRACT:

SUBMITTER: Van Oekelen O 

PROVIDER: S-EPMC9666639 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature